Biomonitoring for workplace exposure to hazardous substances and PFAS
PFAS exposure may have an increased risk of adverse health effects in humans. Biomonitoring for workplace exposure helps to establish baselines for employees and employers. Establishing baselines allows your organization to make better informed decisions to protect workers and assist in assessing measures used to control exposure.
We’re here to help with your PFAS biomonitoring needs
Biomonitoring for PFAS exposure is important. NMS Labs, a CLIA certified, globally recognized, toxicology laboratory, has become the trusted partner to industry leaders, researchers, and governmental agencies for their exposure monitoring needs.
In 2001, NMS Labs began analyzing human serum for PFAS for some of the world's top chemical producers. Since then, our panels have grown to include an array of PFAS compounds prevalent in industrial applications, including aqueous film-forming foam (AFFF).
NMS Labs commitment to PFAS and environmental hazards
PFAS is an emerging area for clinical health and concern. Because of this, NMS Labs is committed to staying in the forefront of the science of PFAS by continually investing in innovation, client experience, and expansion of our PFAS panels.
President and Chief Executive Officer